Medication poisoning main cause of unnatural death in Epilepsy Dr. Kamal Kant Kohli Kohli20 April 2018 7:15 PM ISTPeople with epilepsy are at increased risk of mortality, but, to date, the cause-specific risks of all unnatural causes have not been reported.Dr. ...
Levorphanol a potent & safer analgesic option compared to Morphine : Study Medha Baranwal Baranwal23 April 2018 7:25 PM ISTLevorphanol is a potent analgesic used for the treatment of acute, cancer and neuropathic pain. Valerie Le Rouzic, a researcher at Department of...
New IBS Treatment granted fast track status by FDA Vinay Singh singh3 May 2018 7:25 PM ISTU.S. Food and Drug Administration (FDA) granted Fast Track designation for the Company's lead candidate ORP-101 for the treatment of irritable bowel...
Liposomal bupivacaine not beneficial for pain management after knee surgery Anjali Nimesh Nimesh23 May 2018 7:10 PM ISTContrary to what previous trials have suggested, liposomal bupivacaine, a local anesthetic drug, was not associated with improvement in inpatient...
Liposomal bupivacaine inferior to opioids for managing pain in TKA Medha Baranwal Baranwal7 Jun 2018 7:20 PM ISTThe administration of liposomal bupivacaine in patients undergoing TKA, total knee arthroplasty is not associated with resource utilization, a...
Oral acetaminophen as good as IV acetaminophen in colectomy patients Vinay Singh singh22 Jun 2018 7:05 PM ISTIntravenous (IV) acetaminophen is no more superior in efficacy than oral acetaminophen for patients undergoing colorectal procedures, according to a...
New safe drug for treatment of Chronic Low Back Pain Vinay Singh singh6 Aug 2018 7:20 PM ISTThe U.S. Food and Drug Administration (FDA) has filed and accepted for review the New Drug Application (NDA) for NKTR-181 for the treatment of chronic...
Lofexidine is new effective option for opioids withdrawal symptoms Vinay Singh singh8 Aug 2018 7:20 PM ISTThe U.S. Food and Drug Administration approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt...
New minimally-invasive, non drug therapy for Pain Management Vinay Singh singh21 Aug 2018 7:25 PM ISTThe SPRINT System is the only percutaneous PNS System cleared by the FDA and indicated for up to 60 days in the back and/or extremities for both...
FDA approves new dosage of buprenorphine and naloxone for opioid dependence Hina Zahid8 Sept 2018 7:20 PM ISTThe U.S. Food and Drug Administration today approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the...
Methylprednisolone effectively controls post operative pain in Total knee arthroplasty Vinay Singh singh13 Sept 2018 7:25 PM ISTMethylprednisolone could significantly decrease postoperative pain score, narcotic consumption and opioid-related adverse effects after total knee...
Dexmedetomidine reduces agitation and desflurane requirement during nasal surgery Vinay Singh singh18 Sept 2018 7:05 PM ISTDexmedetomidine significantly reduced the incidence of emergence agitation (EA) and requirement of desflurane in patients undergoing nasal surgery,...
